Ryvu Therapeutics is a clinical stage biopharmaceutical company developing novel small molecule therapies addressing high value emerging targets in precision oncology.
Ryvu Therapeuctis was founded in 2007 and currently employs 150 scientists, including 80 Ph.Ds. Ryvu was previously known as Selvita, until renamed to Ryvu Therapeutics after spin out of the services segment.
The company is headquartered in Kraków, Poland...
Ryvu Therapeutics is a clinical stage biopharmaceutical company developing novel small molecule therapies addressing high value emerging targets in precision oncology.
Ryvu Therapeuctis was founded in 2007 and currently employs 150 scientists, including 80 Ph.Ds. Ryvu was previously known as Selvita, until renamed to Ryvu Therapeutics after spin out of the services segment.
The company is headquartered in Kraków, Poland. Ryvu Therapeutics is developing therapeutics that address clinical limitations of current treatments in oncology.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.